Elvira Yunita

4PUBLICATIONS
5CO-AUTHORS
Traditional, complementary and integrative medicine not elsewhere classifiedChiropracticMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 12, 2026
Correction: Yunita et al. Scoping Review: The Role of Tocotrienol-Rich Fraction as a Potent Neuroprotective Agent. Int. J. Mol. Sci. 2025, 26, 7691.

|Aug 28, 2025
Scoping Review: The Role of Tocotrienol-Rich Fraction as a Potent Neuroprotective Agent.

Elvira Yunita, Muhammad Luqman Nasaruddin, Nur Zuliani Ramli

|Nov 19, 2020
In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.

Septelia Inawati Wanandi, Agus Limanto, Elvira Yunita

|Sep 28, 2020
Suppression of Rotenone-Treated Human Breast Cancer Stem Cell Survival Using Survivin Inhibitor YM155 is Associated to Oxidative Stress Modulation.

Resda A Syahrani, Elvira Yunita, Septelia I Wanandi

Pageof 1

Frequent Collaborators

2 joint publications

Resda Akhra Syahrani

2 joint publications

Septelia Inawati Wanandi

2 joint publications

Muhammad Luqman Nasaruddin

2 joint publications

Nur Zuliani Ramli